FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3086041619> ?p ?o ?g. }

• W3086041619 endingPage "e20.00031" @default.
• W3086041619 startingPage "e20.00031" @default.
• W3086041619 abstract "Osteogenesis imperfecta (OI), a heritable connective tissue disorder with wide clinical variability, predisposes to recurrent fractures and bone deformity. Management requires a multidisciplinary approach in which intramedullary rodding plays an important role, especially for moderate and severe forms. We investigated the patterns of surgical procedures in OI in order to establish the benefits of rodding. The main hypothesis that guided this study was that rodded participants with moderate and severe OI would have lower fracture rates and better mobility.With data from the Linked Clinical Research Centers, we analyzed rodding status in 558 individuals. Mobility and fracture data in OI Types III and IV were compared between rodded and non-rodded groups. Univariate regression analyses were used to test the association of mobility outcomes with various covariates pertinent to rodding.Of the individuals with OI, 42.1% had undergone rodding (10.7% of those with Type I, 66.4% with Type III, and 67.3% with Type IV). Rodding was performed more frequently and at a younger age in femora compared with tibiae. Expanding intramedullary rods were used more frequently in femora. In Type III, the rate of fractures per year was significantly lower (p ≤ 0.05) for rodded bones. In Type III, the mean scores on the Gillette Functional Assessment Questionnaire (GFAQ) and Brief Assessment of Motor Function (BAMF) were higher in the rodded group. However, Type-IV non-rodded subjects had higher mean scores in nearly all mobility outcomes. OI type, the use of expanding rods in tibiae, and anthropometric measurements were associated with mobility outcomes scores.Current practice in 5 orthopaedic centers with extensive experience treating OI demonstrates that most individuals with moderate and severe types of OI undergo rodding procedures. Individuals with severe OI have improved mobility outcomes and lower fracture rates compared with their non-rodded peers, which suggests that early bilateral rodding benefits OI Type III. Our analysis showed a change in practice patterns in the final years of the study in the severe forms, with earlier and more simultaneous rodding procedures performed.Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence." @default.
• W3086041619 created "2020-09-21" @default.
• W3086041619 creator A5004211693 @default.
• W3086041619 creator A5007884388 @default.
• W3086041619 creator A5008415946 @default.
• W3086041619 creator A5023842045 @default.
• W3086041619 creator A5069221744 @default.
• W3086041619 creator A5087951363 @default.
• W3086041619 date "2020-01-01" @default.
• W3086041619 modified "2023-09-26" @default.
• W3086041619 title "A Multicenter Study of Intramedullary Rodding in Osteogenesis Imperfecta" @default.
• W3086041619 cites W1592271535 @default.
• W3086041619 cites W1768653510 @default.
• W3086041619 cites W1776641035 @default.
• W3086041619 cites W1843660700 @default.
• W3086041619 cites W1900428395 @default.
• W3086041619 cites W1968095354 @default.
• W3086041619 cites W1968882957 @default.
• W3086041619 cites W1991453189 @default.
• W3086041619 cites W1992948544 @default.
• W3086041619 cites W1995869907 @default.
• W3086041619 cites W2001478403 @default.
• W3086041619 cites W2007684928 @default.
• W3086041619 cites W2017220638 @default.
• W3086041619 cites W2017750157 @default.
• W3086041619 cites W2021371637 @default.
• W3086041619 cites W2030736429 @default.
• W3086041619 cites W2037561180 @default.
• W3086041619 cites W2058651094 @default.
• W3086041619 cites W2072863928 @default.
• W3086041619 cites W2090617933 @default.
• W3086041619 cites W2094672383 @default.
• W3086041619 cites W2099431176 @default.
• W3086041619 cites W2102048478 @default.
• W3086041619 cites W2105435678 @default.
• W3086041619 cites W2107993163 @default.
• W3086041619 cites W2114218383 @default.
• W3086041619 cites W2127142170 @default.
• W3086041619 cites W2136354070 @default.
• W3086041619 cites W2150740651 @default.
• W3086041619 cites W2154974204 @default.
• W3086041619 cites W2269043730 @default.
• W3086041619 cites W2319553207 @default.
• W3086041619 cites W2332433701 @default.
• W3086041619 cites W2466209127 @default.
• W3086041619 cites W2743704722 @default.
• W3086041619 cites W2748537881 @default.
• W3086041619 cites W2810102057 @default.
• W3086041619 cites W2889151065 @default.
• W3086041619 cites W2893917641 @default.
• W3086041619 cites W2898411672 @default.
• W3086041619 cites W2940109536 @default.
• W3086041619 cites W2949853766 @default.
• W3086041619 cites W2958913057 @default.
• W3086041619 cites W4211060251 @default.
• W3086041619 cites W4235591562 @default.
• W3086041619 cites W4238650946 @default.
• W3086041619 cites W4319721196 @default.
• W3086041619 doi "https://doi.org/10.2106/jbjs.oa.20.00031" @default.
• W3086041619 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7489747" @default.
• W3086041619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32984750" @default.
• W3086041619 hasPublicationYear "2020" @default.
• W3086041619 type Work @default.
• W3086041619 sameAs 3086041619 @default.
• W3086041619 citedByCount "5" @default.
• W3086041619 countsByYear W30860416192022 @default.
• W3086041619 countsByYear W30860416192023 @default.
• W3086041619 crossrefType "journal-article" @default.
• W3086041619 hasAuthorship W3086041619A5004211693 @default.
• W3086041619 hasAuthorship W3086041619A5007884388 @default.
• W3086041619 hasAuthorship W3086041619A5008415946 @default.
• W3086041619 hasAuthorship W3086041619A5023842045 @default.
• W3086041619 hasAuthorship W3086041619A5069221744 @default.
• W3086041619 hasAuthorship W3086041619A5087951363 @default.
• W3086041619 hasBestOaLocation W30860416191 @default.
• W3086041619 hasConcept C105702510 @default.
• W3086041619 hasConcept C126322002 @default.
• W3086041619 hasConcept C141071460 @default.
• W3086041619 hasConcept C144301174 @default.
• W3086041619 hasConcept C195121873 @default.
• W3086041619 hasConcept C2777668750 @default.
• W3086041619 hasConcept C2779982284 @default.
• W3086041619 hasConcept C38180746 @default.
• W3086041619 hasConcept C71924100 @default.
• W3086041619 hasConcept C92162645 @default.
• W3086041619 hasConceptScore W3086041619C105702510 @default.
• W3086041619 hasConceptScore W3086041619C126322002 @default.
• W3086041619 hasConceptScore W3086041619C141071460 @default.
• W3086041619 hasConceptScore W3086041619C144301174 @default.
• W3086041619 hasConceptScore W3086041619C195121873 @default.
• W3086041619 hasConceptScore W3086041619C2777668750 @default.
• W3086041619 hasConceptScore W3086041619C2779982284 @default.
• W3086041619 hasConceptScore W3086041619C38180746 @default.
• W3086041619 hasConceptScore W3086041619C71924100 @default.
• W3086041619 hasConceptScore W3086041619C92162645 @default.
• W3086041619 hasIssue "3" @default.
• W3086041619 hasLocation W30860416191 @default.
• W3086041619 hasLocation W30860416192 @default.

• next